Morning Briefing
Summaries of health policy coverage from major news organizations
A 'Lawful ACIP' Can Meet At Any Time, AAP Contends, Countering RFK Jr.'s Claim
MedPage Today: AAP Disputes Kennedy's Claim That Vaccine Panel Can't Meet Ahead Of Flu Season
The American Academy of Pediatrics (AAP) pushed back on HHS Secretary Robert F. Kennedy Jr.'s claims that the CDC's vaccine panel is unable to meet due to a recent ruling in a lawsuit challenging changes to the U.S. childhood immunization schedule. On June 12, Kennedy took to X to announce the filing of a motion asking the First Circuit Court of Appeals to expedite an appeal of the district court's order that he contended left the Advisory Committee on Immunization Practices (ACIP) "without a quorum." The AAP rebuffed this claim. (Henderson, 6/16)
MedPage Today: Experts Pan RFK Jr.'s Inquiry Into Removal Of Flawed Vaccine Study
Legal and public health experts expressed concern about HHS Secretary Robert F. Kennedy Jr.'s scrutiny of a medical journal's decision to remove a study that purportedly suggested an increased incidence of sudden infant death syndrome (SIDS) within a few days after vaccination. (Frieden, 6/16)
MedPage Today: FDA Staff Weigh In On Potential First MRNA Flu Shot
Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna's mRNA flu vaccine candidate for adults 50 and older, which has the potential to become the first such product approved by the agency. (Rudd, 6/16)
CIDRAP: AI Chatbots Boost Parents’ Willingness To Vaccinate Kids Against HPV, But Only In The Short Term
Parents were more willing to allow their children to receive a vaccine against human papillomavirus (HPV) if they interacted with a chatbot powered by artificial intelligence (AI) compared with parents who received no information about the vaccine. The chatbot’s effects faded after 45 days, suggesting the benefits were short-lived, according to a randomized controlled trial of 1,297 parents of children not yet immunized against HPV. The results were published last week in JAMA Network Open. (Szabo, 6/16)
The latest in science and innovations —
The Baltimore Sun: World's First Therapy To Rejuvenate Cells Given To A Person
A Boston company treated its first patient with a therapy intended to allow aging optic nerve cells to behave as though they were young again. (Hille, 6/16)
MedPage Today: Menopause Experts Release Guidance On Non-Hormone Therapy For Hot Flashes
A multidisciplinary group of menopause experts developed new comorbidity-specific guidance on non-hormone therapy for moderate-to-severe vasomotor symptoms. (Robertson, 6/16)
MedPage Today: Lifestyle Change In Prediabetes Cuts Risk Of Multimorbidity
Adults with prediabetes randomized to a lifestyle intervention had a significantly lower risk of developing multiple chronic conditions over time compared with a placebo group, a benefit not seen among those assigned to metformin, long-term data from the Diabetes Prevention Program (DPP) trial showed. (Monaco, 6/16)
